ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2770

Complex Functional Effects Within The HLA Contribute To Sjögren’s Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding

Christopher J. Lessard1,2, He Li1, Indra Adrianto1, John A. Ice1, Mikhail G. Dozmorov3, Roland Jonsson4, Maureen Rischmueller5, Gunnel Nordmark6, Xavier Mariette7, Corinne Miceli-Richard8, Marie Wahren-Herlenius9, Torsten Witte10, Michael T. Brennan11, Roald Omdal12, Lars Rönnblom13, Patrick M. Gaffney1, Wan-Fai Ng14, Nelson L. Rhodus15, Barbara M. Segal16, Jonathan D. Wren1, R. Hal Scofield1,17,18, Juan-Manuel Anaya19, John B. Harley20,21, Courtney G. Montgomery1 and Kathy L. Sivils1,2, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Arthritis and Clincial Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, 5Rheumatology Department, Queen Elizabeth Hospital, Adelaide, Australia, 6Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 7Paris-Sud University, Paris, France, 8Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France, 9Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 10Clinical Immunology and Rheumatology, Medical University Hannover, Hanover, Germany, 11Nidcr NIH, Carolinas Medical Center, Charlotte, NC, 12Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, 13Department of Medical Science, Uppsala University, Uppsala, Sweden, 14Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle upon Tyne, United Kingdom, 15University of Minnesota, Minneapolis, MN, 16Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 17Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 18US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 19School of Medicine and Health Sciences, Universidad del Rosario. Center for Autoimmune Diseases Research (CREA), Bogotá, Colombia, 20Division of Rheumatology and The Center for Autoimmune Genomics & Etiology, University of Cincinnati, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 21US Department of Veterans Affairs Medical Center, Cincinnati, OH

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: GWAS, human leukocyte antigens (HLA), pathogenesis and transcriptional regulation, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome: Basic Science

Session Type: Abstract Submissions (ACR)

Background/Purpose: Primary Sjögren’s syndrome (pSS) is a common, heterogeneous exocrinopathy.  Etiology involves complex environmental, genetic and genomic influences driving innate and adaptive autoimmune responses.  This study sought to integrate genome-wide association study (GWAS) and classical HLA allele associations in SS, and to explore this genetically complex region for insight into disease mechanisms through bioinformatic approaches.

Methods: Genotype data was collected for 1638 pSS cases and 6754 controls on Illumina Omni1-Quad or ImmunoChip arrays. HLA classical allele imputation was performed using HiBag with a certainty threshold of >80% to define relationships with single nucleotide polymorphisms (SNPs).  A set of 9122 pSS associated SNPs (P<5x10E-5) were tested for enrichment using GenomeRunner to determine if the set of SNPs co-localize with various functional genomic elements such as specific transcription factor binding sites.  A subset of SS associated SNPs that were significantly enriched in genomic locations near functional elements related to the transcriptional regulator, RFX5, were tested by expression quantitative trait locus (eQTL) analysis using the MATRIXeQTL package in R using transcript levels measured by Illumina WG-6 arrays in 133 subjects.

Results: After adjusting for the most significant GWAS variant (rs115575857 in HLA Class II; P=1.65x10E-114), we found a second independent effect peaking at rs116232857 (P=1.33x10E-96).  Imputation and regression analyses identified the previously reported ancestral haplotype including DQB1*0201 (P=1.38x10E-95), DQA1*0501 (P=8.50x10E-94), and DRB1*0301 (P=2.19x10E-84) and indicated rs115575857 was synonymous with this haplotype.  The association at rs116232857 persisted and accounted for DQB1*0501, but DQB1*0501 could not account for rs116232857, suggesting rs116232857 either tags multiple functional effects or, alternatively, DQB1*0501 is a false positive.  Statistically significant co-localization (P=1.53x10E-14) was observed showing that 160 HLA region variants are located within or near (100 bp) ChIP-seq peaks for RFX5, a key transcriptional regulator of HLA Class I and II loci.  Further analyses of RFX5 related variants identified multiple eQTLs (P-values between 8.31x10E-11 and 4.54x10E-33) in both the Class I and Class II HLA loci and include HLA-DRB6, HLA-C, HLA-DPB1, HLA-DQA1, and HLA-A.  Risk alleles for these eQTLs reside on both pSS associated haplotypes.

Conclusion: We conclude that the ancestral haplotype of DQB1*0201, DQA1*0501, and DRB1*0301 corresponds to our top GWAS effect, rs115575857 and the second independent effect at rs116232857 is novel.  RFX5 was identified as a novel potential functional candidate as the RFX5 binding elements were enriched for pSS associated variants affecting HLA Class I and II expression levels. This work suggests that complex functional elements in the HLA region involved in both transcriptional regulation and peptide binding impact SS.


Disclosure:

C. J. Lessard,
None;

H. Li,
None;

I. Adrianto,
None;

J. A. Ice,
None;

M. G. Dozmorov,
None;

R. Jonsson,
None;

M. Rischmueller,
None;

G. Nordmark,
None;

X. Mariette,
None;

C. Miceli-Richard,
None;

M. Wahren-Herlenius,
None;

T. Witte,
None;

M. T. Brennan,
None;

R. Omdal,
None;

L. Rönnblom,
None;

P. M. Gaffney,
None;

W. F. Ng,
None;

N. L. Rhodus,
None;

B. M. Segal,
None;

J. D. Wren,
None;

R. H. Scofield,
None;

J. M. Anaya,
None;

J. B. Harley,
None;

C. G. Montgomery,
None;

K. L. Sivils,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/complex-functional-effects-within-the-hla-contribute-to-sjogrens-syndrome-pathogenesis-and-may-influence-both-transcriptional-regulation-and-peptide-binding/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology